Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
OBX-115 by Obsidian Therapeutics for Metastatic Melanoma: Likelihood of Approval
OBX-115 is under clinical development by Obsidian Therapeutics and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...
OBX-115 by Obsidian Therapeutics for Solid Tumor: Likelihood of Approval
OBX-115 is under clinical development by Obsidian Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
OBX-115 by Obsidian Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
OBX-115 is under clinical development by Obsidian Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...